Implantica Management
Management criteria checks 3/4
Implantica's CEO is Peter Forsell, appointed in Jan 2015, has a tenure of 10.33 years. total yearly compensation is €208.35K, comprised of 99.7% salary and 0.3% bonuses, including company stock and options. directly owns 96.49% of the company’s shares, worth SEK8.42B. The average tenure of the management team and the board of directors is 3.8 years and 5.3 years respectively.
Key information
Peter Forsell
Chief executive officer
€208.4k
Total compensation
| CEO salary percentage | 99.75% |
| CEO tenure | 10.3yrs |
| CEO ownership | 96.5% |
| Management average tenure | 3.8yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Here's Why We're Not Too Worried About Implantica's (STO:IMP A SDB) Cash Burn Situation
Apr 18
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -€23m |
| Dec 31 2024 | €208k | €208k | -€23m |
| Sep 30 2024 | n/a | n/a | -€25m |
| Jun 30 2024 | n/a | n/a | -€24m |
| Mar 31 2024 | n/a | n/a | -€23m |
| Dec 31 2023 | €204k | €204k | -€24m |
| Sep 30 2023 | n/a | n/a | -€20m |
| Jun 30 2023 | n/a | n/a | -€20m |
| Mar 31 2023 | n/a | n/a | -€21m |
| Dec 31 2022 | €200k | €200k | -€21m |
Compensation vs Market: Peter's total compensation ($USD231.32K) is below average for companies of similar size in the Swedish market ($USD752.51K).
Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.
CEO
Peter Forsell (70 yo)
10.3yrs
Tenure
€208,354
Compensation
Dr. Med. Peter Forsell founded Implantica AG in 2015 and serves as its Chief Executive Officer since 2015.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & CEO | 10.3yrs | €208.35k | 96.49% SEK 8.4b | |
| Chief Financial Officer | 5.3yrs | no data | 0.0084% SEK 735.3k | |
| Chief Strategy Officer & Board Member | no data | no data | 0.32% SEK 27.7m | |
| Chief Corporate Affairs Officer | 2.9yrs | no data | 0.19% SEK 16.1m | |
| Vice President of Marketing & Advocacy | 3.3yrs | no data | no data | |
| Chief Market Access & Strategy Officer | 4.3yrs | no data | no data | |
| Senior Director & Head of Global QA RA | 2.3yrs | no data | no data | |
| Company Secretary & Member of Advisory Board | no data | no data | no data |
3.8yrs
Average Tenure
61yo
Average Age
Experienced Management: IMP A SDB's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Strategy Officer & Board Member | 5.3yrs | no data | 0.32% SEK 27.7m | |
| Company Secretary & Member of Advisory Board | no data | no data | no data | |
| Independent Chair of the Board | 5.3yrs | €37.19k | 0.0099% SEK 867.0k | |
| Independent Board Member | 4.8yrs | €48.09k | 0.0071% SEK 615.8k | |
| Member of Advisory Board | no data | no data | no data | |
| Vice-Chairman of the Board | 5.3yrs | €10.70k | 0.047% SEK 4.1m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.3yrs
Average Tenure
66yo
Average Age
Experienced Board: IMP A SDB's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/13 19:37 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Implantica AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christian Lee | Pareto Securities |
| Chien-Hsun Lee | Pareto Securities |